Pfizer guts it out in obesity, diabetes deal with Second Genome
May 02, 2014 at 10:02 AM EDT
Pfizer Inc., with the help of South San Francisco’s Second Genome, wants to peer into the gut to discover how the cast of bacterial characters there plays a role in obesity and diabetes...